Tuesday, March 29, 2022

FDA approves another Pfizer, Moderna COVID-19 booster for 50 and up

U.S. regulators on Tuesday authorized another COVID-19 booster for people age 50 and older, a step to offer extra protection for the most vulnerable in case the coronavirus rebounds. The Food and Drug Administration's decision opens a fourth dose of the Pfizer or Moderna vaccines to those people at least four months after their previous booster.

No comments:

Post a Comment